MarvelBiome
Woburn, US · Founded 2019 · Delaware corporation
Marvel Biome researches the microbiome to develop therapeutics based on the therapeutic potential of microbes. The company operates in the biotechnology and wellness space.
Founders & leadership
EJ
Elamparithi JayamaniChief Technical Officer
JA
J. Amaranath GovindanPresident and Chief Scientific Officer
PC
Priti ChatterNamed on SEC filing
MC
Mukesh ChatterNamed on SEC filing
Board
GZ
G. Zachary GundBoard director
GR
Gary RuvkunBoard director
RE
Rudolph E. TanziBoard director
Reported raises · per SEC filings
Form D private placements$54.9M disclosed across 4 rounds · 2020–2025
▶$39.6MraisedOct 2025 · 10 investors · BiotechnologyRule 506(b)
▶$39.6MraisedOct 2025 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Priti ChatterDirector
- G. Zachary GundDirector
- Elamparithi JayamaniExecutive Officer
- Gary RuvkunDirector
- Mukesh ChatterDirector
- Rudolph E. TanziDirector
- J. Amaranath GovindanExecutive Officer, Director
- Offering amount
- $52.5M
- Amount sold
- $39.6M
- First sale
- Oct 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10MraisedAug 2023 · 1 investors · BiotechnologyRule 506(b)
▶$10MraisedAug 2023 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Gary RuvkunDirector
- Rudolph TanziDirector
- Elamparithi JayamaniExecutive Officer
- Jothi Amaranath GovindanExecutive Officer, Director
- Priti ChatterDirector
- Mukesh ChatterDirector
- Offering amount
- $10M
- Amount sold
- $10M
- First sale
- Jul 2023
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$3.1MraisedNov 2020 · 6 investors · BiotechnologyRule 506(b)
▶$3.1MraisedNov 2020 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Elamparithi JayamaniExecutive Officer
- Jothi Amaranath GovindanExecutive Officer, Director
- Priti ChatterDirector
- Rudolph TanziDirector
- Gary RuvkunDirector
- Mukesh ChatterDirector
- Offering amount
- $20M
- Amount sold
- $3.1M
- First sale
- Nov 2020
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$2.3MraisedJun 2020 · 2 investors · BiotechnologyRule 506(b)
▶$2.3MraisedJun 2020 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jothi Amaranath GovindanExecutive Officer, Director
- Elamparithi JayamaniExecutive Officer
- Mukesh ChatterDirector
- Rudolph E. TanziDirector
- Priti ChatterDirector
- Gary RuvkunDirector
- Offering amount
- $2.3M
- Amount sold
- $2.3M
- First sale
- Jun 2020
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 8
by search overlap
Holobiome, Inc.5 shared keywordsHolobiome discovers and develops therapies derived from the human gut microbiome, working to translate microbiome science into probiotics and targeted treatments for whole-body health. The company was founded by research scientists from Northeastern University.
BIOHM5 shared keywordsBIOHM sells probiotic supplements and at-home gut test kits that analyze the microbiome, with results reviewed by a microbiome-trained registered nutritionist who provides personalized diet and supplement recommendations. Its formula combines bacteria, fungi, and a digestive enzyme intended to support digestive health.
Biomesense5 shared keywordsBiomeSense builds an AI-enabled platform combining hardware (GutLab) and bioinformatics (MetaBiome) to continuously generate and analyze gut microbiome data. It serves scientists, institutions, and companies conducting clinical research on the microbiome for personalized biomarker discovery and product development.
Biome Analytics4 shared keywordsBiome provides analytics tools for healthcare leaders, focused on improving cardiovascular care outcomes and reducing operational inefficiency. It serves hospitals and cardiac care centers, offering data-driven products including the Biome Performance Network for clinical and operational decision-making.
Viome4 shared keywordsViome offers at-home tests that analyze the gut and oral microbiome plus cellular blood samples using mRNA/metatranscriptomic sequencing, returning 70+ health scores (including biological age and inflammation) and personalized food and supplement recommendations. The direct-to-consumer service, analyzed in a CLIA-certified lab, is aimed at individuals seeking insights into digestion, metabolism, and overall wellness.
Pendulum3 shared keywordsPendulum is a probiotic and prebiotic supplement company that develops clinically-tested products targeting gut health, metabolic function, and glucose control, including proprietary strains like live Akkermansia.
Agbiome3 shared keywordsUS agricultural biotech that discovered microbe-based crop protection products; its assets were sold to Certis Biologicals and Ginkgo Bioworks in 2024.
EquityZen3 shared keywordsEquityZen operates an online marketplace that gives accredited individual investors access to shares in late-stage private companies through secondary market transactions. Now part of Morgan Stanley, the platform provides private market data, offering documents, and guided investment processes for buying and selling pre-IPO equity.
Companies competing with MarvelBiome for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does MarvelBiome do?
- Marvel Biome researches the microbiome to develop therapeutics based on the therapeutic potential of microbes. The company operates in the biotechnology and wellness space.
- How much funding has MarvelBiome raised?
- MarvelBiome has disclosed $54.9M raised across 4 rounds.
- Where is MarvelBiome headquartered?
- MarvelBiome is headquartered in Woburn, US.